Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–1108. doi:10.1016/S0140-6736(10)60826-420870100
   PubMed Web of Science ®Google Scholar
• Zeng XF, Zhu SI, Tan XP, et al. Disease burden and quality of life of rheumatoid arthritis in China: a systematic review. Chin J Evid Based Med. 2013;13:300–307.
   Google Scholar
• Chou GX, Norio N, Ma CM, et al. Isoquinoline alkaloids from Lindera aggregate. Chin J Nat Med. 2005;03(5):272–275.
   Google Scholar
• Luo Y, Liu M, Xia Y, et al. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Phytomedicine. 2010;17(10):726–731. doi:10.1016/j.phymed.2010.01.01320363113
   PubMed Web of Science ®Google Scholar
• Wei ZF, Jiao XL, Wang T, et al. Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE (2), and MMP-13 expression. Acta Pharmacol Sin. 2013;34(3):403–413. doi:10.1038/aps.2012.18723396374
   PubMed Web of Science ®Google Scholar
• Tong B, Dou Y, Wang T, et al. Norisoboldine ameliorates collagen-induced arthritis through regulating the balance between Th17 and regulatory T cells in gut-associated lymphoid tissues. Toxicol Appl Pharmacol. 2015;282(1):90–99. doi:10.1016/j.taap.2014.11.00825481498
   PubMed Web of Science ®Google Scholar
• Lu Q, Lu S, Gao XH, et al. Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype. Exp Biol Med. 2012;237:919–932. doi:10.1258/ebm.2012.011416
   Web of Science ®Google Scholar
• Lu Q, Tong B, Luo YB, et al. Norisoboldine suppresses VEGF-induced endothelial cell migration via the cAMP-PKA-NF-κB/Notch1 pathway. PLoS One. 2013;8:12. doi:10.1371/journal.pone.0081220
   Web of Science ®Google Scholar
• Chen JZ, Chou GX, Wang CH, et al. Pharmacokinetics and bioavailability of norisoboldine and its metabolite in Rats. Chin JMAP. 2012;29(6):473–477.
   Google Scholar
• Eltobshi AA, Mohamed EA, Abdelghani GM, et al. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein. Int J Nanomedicine. 2018;13(1):5887–5907. doi:10.2147/IJN.S17414630319255
   PubMedGoogle Scholar
• Salem HF, Kharshoum RM, Saved OM, et al. Formulation development of self-nanoemulsifying drug delivery system of celecoxib for the management of oral cavity inflammation. J Liposome Res. 2018;23:1–11.
   Google Scholar
• Baldi A, Chaudhary M, Sethi S, et al. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: in silico docking patronage, absorption pheonmenon, preclinical status, clinical status and future prospects. Colloids Surf B Biointerfaces. 2018;170:637–647. doi:10.1016/j.colsurfb.2018.06.06129986259
   PubMedGoogle Scholar
• Buyukozturk F, Benneyan JC, Carrier RL. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release. 2010;142(1):22–30. doi:10.1016/j.jconrel.2009.10.00519850092
   PubMed Web of Science ®Google Scholar
• Mamadou G, Charrueau C, Dairou J, et al. Increased intestinal permeation and modulation of presystemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems. Int J Pharm. 2017;521(1–2):150–155. doi:10.1016/j.ijpharm.2017.02.03628216465
   PubMedGoogle Scholar
• Valicherla GR, Dave KM, Syed AA, et al. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Sci Rep. 2016;6:26895. doi:10.1038/srep2689527241877
   PubMed Web of Science ®Google Scholar
• Shen JY, Bi JP, Tian HL, et al. Preparation and evaluation of a self-nanoemusifying drug delivery system loaded with akebia saponin D-phospholipid complex. Int J Nanomedicine. 2016;11:4919–4929. doi:10.2147/IJN.S10876527713630
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng Q, Shi S, et al. Preparation, charaterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomedicine. 2011;6:3405–3414. doi:10.2147/IJN.S2582422267925
   PubMed Web of Science ®Google Scholar
• Xiao YY, Song YM, Chen ZP, et al. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm. 2006;307(1):77–82. doi:10.1016/j.ijpharm.2005.10.00116300915
   PubMedGoogle Scholar
• Manconi M, Nácher A, Merino V, et al. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. AAPS PharmSciTech. 2013;14(2):485–496. doi:10.1208/s12249-013-9926-423471836
   PubMedGoogle Scholar
• Eriksson LC. Preparation of liver microsomes with high recovery of endoplasmic reticulum and a low grade of contamination. Biochim Biophys Acta. 1978;508(1):155–164. doi:10.1016/0005-2736(78)90197-9629966
   PubMedGoogle Scholar
• Jena SK, Singh C, Dora CP, et al. Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability. Int J Pharm. 2014;473(1–2):1–9. doi:10.1016/j.ijpharm.2014.06.05624992316
   PubMedGoogle Scholar
• Hou Z, Li Y, Huang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm. 2013;10(1):90–101. doi:10.1021/mp300489p23194396
   PubMed Web of Science ®Google Scholar
• Larsen AT, Ohlsson AG, Polentarutti B, et al. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation. Eur J Pharm Sci. 2013;48(1–2):339–350. doi:10.1016/j.ejps.2012.11.00423178440
   PubMed Web of Science ®Google Scholar
• Nielsen FS, Petersen KB, Mullertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm. 2008;69(2):553–562. doi:10.1016/j.ejpb.2007.12.02018294829
   PubMed Web of Science ®Google Scholar
• Date AA, Desai N, Dixit R, et al. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine(Lond). 2010;5(10):1595–1616. doi:10.2217/nnm.10.12621143036
   PubMed Web of Science ®Google Scholar
• Sun M, Zhai X, Xue K, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 2011;43(3):132–140. doi:10.1016/j.ejps.2011.04.01121530655
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci. 2005;24(4):381–388. doi:10.1016/j.ejps.2004.12.00615734305
   PubMed Web of Science ®Google Scholar
• Griffin BT, O’Driscoll CM. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol. 2006;58(7):917–925. doi:10.1211/jpp.58.7.000616805951
   PubMed Web of Science ®Google Scholar
• Chen JZ, Chou GX, Wang CH, et al. Characterization of new metabolites from in vivo biotransformation of norisoboldine by liquid chromatography/mass spectrometry and NMR spectroscopy. J Pharm Biomed Anal. 2010;52(5):687–693. doi:10.1016/j.jpba.2010.02.00820223612
   PubMed Web of Science ®Google Scholar